Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)
EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N-glycosylated epitope found on both CEACAM5 and CEACAM6. The expansion cohort for pancreatic ductal adenocarcinoma (PDAC) in the ongoing Phase 1 trial has...
Video: CEO presentation at Minesto's Capital Market Day 2024
The CEO presentation from Minesto's Capital Market Day is now available on the company's website and YouTube channel. The Capital Market Day was held on 11 December 2024 at the company's workshop in Gothenburg, Sweden. GOTHENBURG, Sweden, Dec. 17,...